Assignee
LENZ HEINZ-JOSEF
US·6 granted patents·20 pending applications·1 citations·filing 2008–2017
Top patents by PatentIndex Score
26 records- 0165US8568968B2EGFR polymorphisms predict gender-related treatmentLENZ HEINZ-JOSEF·Filed 2010·Granted Oct 29, 2013·1 cites·12 claims
- 0262US8435752B2Gene polymorphisms predictive for dual TKI therapyLENZ HEINZ-JOSEF·Filed 2008·Granted May 7, 2013·0 cites·6 claims
- 0361US2013196955A1Polymorphisms for predicting disease and treatment outcomeLENZ HEINZ-JOSEF·Filed 2013·Application pending·0 cites
- 0454US8318426B2Polymorphisms in voltage-gated sodium channel alpha 1-subunit as markers for therapy selectionLENZ HEINZ-JOSEF·Filed 2010·Granted Nov 27, 2012·0 cites·7 claims
- 0554US2010184773A1Germline Polymorphisms in the Angiogenic Pathway Predict Tumor Recurrence in Cancer TherapyLENZ HEINZ-JOSEF·Filed 2008·Application pending·0 cites
- 0652US2010099720A1Gene Polymorphisms as Sex-Specific Predictors in Cancer TherapyLENZ HEINZ-JOSEF·Filed 2008·Application pending·0 cites
- 0749US2012122946A1Polymorphisms for predicting disease and treatment outcomeLENZ HEINZ-JOSEF·Filed 2011·Application pending·0 cites
- 0848US10563267B2Polymorphism biomarkers predict clinical outcomes of cancer patients receiving regorafenibLENZ HEINZ JOSEF·Filed 2017·Granted Feb 18, 2020·0 cites·15 claims
- 0948US2014005064A1Polymorphisms in angiogenesis pathway genes associated with tumor recurrence in surgery treated cancer patientsLENZ HEINZ-JOSEF·Filed 2013·Application pending·0 cites
- 1047US2012094291A1FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOMELENZ HEINZ-JOSEF·Filed 2011·Application pending·0 cites
- 1146US8278061B2Polymorphisms in the EGFR pathway as markers for cancer treatmentLENZ HEINZ-JOSEF·Filed 2008·Granted Oct 2, 2012·0 cites·5 claims
- 1246US8216781B2Gene polymorphisms as predictors of tumor progression and their use in cancer therapyLENZ HEINZ-JOSEF·Filed 2008·Granted Jul 10, 2012·0 cites·25 claims
- 1346US2012289410A1Genetic variant in formyl peptide receptor 2 (fpr2) predicts clinical outcome in cancer patientsLENZ HEINZ-JOSEF·Filed 2012·Application pending·0 cites
- 1445US2012289424A1Igf1r polymorphism predicts tumor recurrence in breast cancer patientsLENZ HEINZ-JOSEF·Filed 2012·Application pending·0 cites
- 1544US2012129178A1Genomic polymorphism for predicting therapeutic responseLENZ HEINZ-JOSEF·Filed 2011·Application pending·0 cites
- 1643US2012107309A1Polymorphism in k-ras 3' untranslated region associated with clinical outcomes of cancer treatments independent of k-ras mutation statusLENZ HEINZ-JOSEF·Filed 2011·Application pending·0 cites
- 1741US2012289592A1Ercc1 gene expression level is associated with clinical outcomes in esophageal cancer patientsLENZ HEINZ-JOSEF·Filed 2012·Application pending·0 cites
- 1841US2012288861A1Germline polymorphisms in the sparc gene associated with clinical outcome in gastric cancerLENZ HEINZ-JOSEF·Filed 2010·Application pending·0 cites
- 1939US2012094844A1Genetic variants in il-6, p53, mmp-9 and cxcr predict clinical outcome in patients with cancerLENZ HEINZ-JOSEF·Filed 2010·Application pending·0 cites
- 2039US2012108441A1Polymorphisms in angiogenesis pathway genes associated with tumor recurrence in surgery treated cancer patientsLENZ HEINZ-JOSEF·Filed 2010·Application pending·0 cites
- 2139US2012077685A1Intratumoral gene expression levels of tp and vegf are associated with clinical outcomes in rectal cancer patients treated with 5-fluorouracil and pelvic radiationLENZ HEINZ-JOSEF·Filed 2011·Application pending·0 cites
- 2239US2012100997A1Cd133 polymorphisms and expression predict clinical outcome in patients with cancerLENZ HEINZ-JOSEF·Filed 2010·Application pending·0 cites
- 2339US2012108445A1Vegf and vegfr1 gene expression useful for cancer prognosisLENZ HEINZ-JOSEF·Filed 2010·Application pending·0 cites
- 2439US2012100134A1Genetic variants in angiogenesis pathway associated with clinical outcomeLENZ HEINZ-JOSEF·Filed 2010·Application pending·0 cites
- 2537US2012107308A1Gene expression levels of egfr, vegfr2, and ercc1 associated with clinical outcomes of chemotherapyLENZ HEINZ-JOSEF·Filed 2010·Application pending·0 cites
- 2636US2012100135A1Genetic polymorphisms associated with clinical outcomes of topoisomerase inhibitor therapy for cancerLENZ HEINZ-JOSEF·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LENZ HEINZ-JOSEF files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →